ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRTC Puretech Health Plc

143.40
-1.20 (-0.83%)
Last Updated: 09:36:31
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.20 -0.83% 143.40 142.80 143.40 147.00 143.40 147.00 67,195 09:36:31
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 65.12M -65.7M -0.2744 -5.28 346.2M
Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 144.60p. Over the last year, Puretech Health shares have traded in a share price range of 136.00p to 238.50p.

Puretech Health currently has 239,421,312 shares in issue. The market capitalisation of Puretech Health is £346.20 million. Puretech Health has a price to earnings ratio (PE ratio) of -5.28.

Puretech Health Share Discussion Threads

Showing 2676 to 2697 of 2800 messages
Chat Pages: 112  111  110  109  108  107  106  105  104  103  102  101  Older
DateSubjectAuthorDiscuss
20/12/2024
07:57
A company more likely to bid £1 billion now than want a commercial deal in a years time after a phase three trial .With cash in bank and royalties to come you would get your £1 billion back with in 5 years with lyt100 producing big cash .
doctor 69
19/12/2024
14:55
Perhaps the firm needs to provide the annual update on 24.12 after the inevitable stock dump

"With analysts forecasting peak LYT-100 sales of $800m per annum on a successful Phase 3 and commercial launch , a potential valuation of c $1.5b to $2b for LYT-100 appears reasonable. Throw in everything else in Puretech from current cash, future royalties from BMS , Seaport and Gallop plus Vedanta et al , and you have a potentially $3/4b enterprise in perhaps 2 years or so.But Mr Market just yawns .However Puretech is now more vulnerable to a bid than ever before imho." from a poster on LSE

nai etc

takeiteasy
19/12/2024
14:36
Trackers...it's coming out of the ftse 250 on 23/12.looks stunning to me.
colinblackbourn
19/12/2024
14:36
Played like a fiddle for months
brianblu
19/12/2024
14:33
short term, the share has not decided whether it is coming or going - selling off like it has had some sort of profit warning rather than the opposite...can only imagine some large holders have to reduce position sizes for wider reasons ?
takeiteasy
19/12/2024
08:01
Superb listen , this could ten bag over next few yrs in my opinion
doctor 69
19/12/2024
07:35
Couple of new projects not yet public.excellent clip.explains a lot.
colinblackbourn
19/12/2024
06:44
https://www.biotechtv.com/post/puretech-health-december-18-2024
colinblackbourn
18/12/2024
16:27
The US Jefferies analyst is forecasting peak sales of $10bn pa.The UK analyst $3.5bn...maybe they should speak to each other.
colinblackbourn
18/12/2024
16:14
edit- more later if I can
jaws6
18/12/2024
15:53
hmm cobenfy should be way north of that - i assume they are just forecasting US alone with that number
edwardt
18/12/2024
15:32
Jeffries note forecasts peak sales LYT 100 $800m pa with a probability of 40pc.Peak sales Cobenfy $3.5bn.
colinblackbourn
18/12/2024
13:17
LYT100 is in for free ....as is the massive upside for Seaport.
colinblackbourn
18/12/2024
12:39
hxxps://in.investing.com/news/analyst-ratings/leerink-partners-raises-puretech-health-target-to-46-maintains-outperform-93CH-4577657
jaws6
18/12/2024
12:38
hxxps://firstwordpharma.com/story/5921940
jaws6
18/12/2024
12:37
pretty clear then i think from this link and the PRTC presentation...have to believe despite DT in USA this can move....
takeiteasy
18/12/2024
12:01
www.marketbeat.com/instant-alerts/puretech-health-lonprtc-given-buy-rating-at-jefferies-financial-group-2024-12-16/
jaws6
18/12/2024
10:54
jaws, try to remove https or www refs and link will stick I think
takeiteasy
18/12/2024
10:51
Year end cash should be $340m as forecast plus $29m Cobenfy milestones less $14m put into Seaport.Seaport has $325m cash with PureTech holding now 37pc.
colinblackbourn
18/12/2024
10:43
Re Cobenfy.we will get $373m in tranches as sales go to $2bn.anything above that we get 2pc.
colinblackbourn
18/12/2024
10:14
can not post link here for some reason but it is in marketbeat
jaws6
18/12/2024
10:13
link- [...]
jaws6
Chat Pages: 112  111  110  109  108  107  106  105  104  103  102  101  Older

Your Recent History

Delayed Upgrade Clock